Lotus Therapeutics Appoints Leslie Felix as Chief Growth Officer
BOCA RATON, Fla. , June 4, 2025 /PRNewswire/ — Lotus Therapeutics, the generic division of Speranza Therapeutics, proudly announces the appointment of Leslie Felix as Chief Growth Officer. With over 25 years of executive experience in the pharmaceutical sector, Felix brings a proven track record in the … Read More